You are here

Article Text

Article menu
PDF
Correspondence response
EULAR recommendations for management of fibromyalgia
  1. Gary J Macfarlane1,
  2. Caroline Kronisch2,
  3. Fabiola Atzeni3,
  4. Winfried Häuser4,5,
  5. Ernest H Choy6,
  6. Kirstine Amris7,
  7. Jaime Branco8,
  8. Fitnat Dincer9,
  9. Paivi Leino-Arjas10,
  10. Kathy Longley11,
  11. Geraldine McCarthy12,
  12. Suzi Makri13,
  13. Serge Perrot14,
  14. Piercarlo Sarzi Puttini15,
  15. Ann Taylor6,
  16. Gareth T Jones1
  1. 1Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
  2. 2Department of Rheumatology, Cantonal Hospital, Fribourg, Switzerland
  3. 3ICRCCS Galeazzi Orthopaedic Institute, Milan, Italy
  4. 4Department of Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany
  5. 5Department of Psychosomatic Medicine, Technische Universität München, München, Germany
  6. 6Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK
  7. 7Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
  8. 8Department of Rheumatology, CEDOC-NOVA Medical School, UNL, CHLO, Hospital Egas Moniz, Lisbon, Portugal
  9. 9Department of Physical and Rehabilitation Medicine, Hacettepe University, Division of Internal Medicine, Ankara, Turkey
  10. 10Finnish Institute of Occupational Health, Helsinki, Finland
  11. 11Patient Representative, UK
  12. 12Mater Misericordiae University Hospital, Dublin, Ireland
  13. 13Patient Representative, Limassol, Cyprus
  14. 14Centre de la Douleur, Hôpital Cochin-Hôtel Dieu, Université Paris Descartes, Paris, France
  15. 15Rheumatology Unit, L. Sacco University Hospital, Milan, Italy
  1. Correspondence to Professor Gary J Macfarlane, Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB24 3FX, UK; g.j.macfarlane{at}abdn.ac.uk

http://dx.doi.org/10.1136/annrheumdis-2017-211587

Statistics from Altmetric.com

    The EULAR recommendations for the management of fibromyalgia are based on more than 100 reviews and meta-analyses of individual therapies and medicines.1 Thus, the quality of the evidence in making recommendations on effectiveness and efficacy is generally very high. In contrast, there is little published research …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

    Linked Articles